Genotype-phenotype correlations in X-linked myotubular myopathy.
X-linked myotubular myopathy is a severe congenital myopathy that presents in the neonatal period with profound hypotonia and an inability to establish spontaneous respiration. Usually death occurs in infancy from respiratory failure. However, there is phenotypic variability; a number of affected boys have achieved respiratory independence and become ambulatory. Disease-causing mutations have been identified throughout the MTM1 gene on Xq28. MTM1 encodes the protein myotubularin, which is expressed ubiquitously. The main objectives of this study were to establish whether the nature or site of the mutation in the MTM1 gene could predict severity of the disease and to investigate whether early intensive clinical intervention facilitated survival until spontaneous improvement occurred. An association was demonstrated between the presence of a non-truncating mutation of the MTM1 gene and the mild phenotype. However, many non-truncating mutations were also seen in association with the severe phenotype and these were not confined to recognized functional domains of the protein. This suggests that the use of mutation analysis to predict prognosis in the early period following diagnosis is limited. Unexpectedly, over 50 patients surviving for more than 1 year were identified in this study. Further information obtained on 40 of these cases revealed that 50% were receiving 24-h ventilatory support, while 27% were ventilated at night only. The high survival rate for this disorder therefore reflects intensive medical intervention without which the majority of these boys would not survive.
McEntagart
Meriel
M
Institute of Medical Genetics, University of Wales College of Medicine, Cardiff, UK. mcentagart@yahoo.co.uk
Parsons
Gretchen
G
Buj-Bello
Anna
A
Biancalana
Valérie
V
Fenton
Iain
I
Little
Mark
M
Krawczak
Michael
M
Thomas
Nick
N
Herman
Gail
G
Clarke
Angus
A
Wallgren-Pettersson
Carina
C
D016009:Chi-Square Distribution; D041321:Chromosomes, Human, X; D004252:DNA Mutational Analysis; D004303:Dosage Compensation, Genetic; D005091:Exons; D005192:Family Health; D005500:Follow-Up Studies; D040181:Genetic Diseases, X-Linked / Q000235:genetics*; D005838:Genotype; D006801:Humans; D008297:Male; D005810:Multigene Family; D009154:Mutation; D020914:Myopathies, Structural, Congenital / Q000235:genetics*; D017063:Outcome Assessment, Health Care; D010641:Phenotype; D018807:Polymorphism, Single-Stranded Conformational; D017027:Protein Tyrosine Phosphatases / Q000235:genetics; D054558:Protein Tyrosine Phosphatases, Non-Receptor; D013223:Statistics as Topic; D016019:Survival Analysis; D013997:Time Factors; D012122:Ventilators, Mechanical / Q000706:statistics & numerical data / Q000600:supply & distribution
D017027:Protein Tyrosine Phosphatases; D054558:Protein Tyrosine Phosphatases, Non-Receptor; C099588:myotubularin